Juthathip Mongkolsapaya

University of Oxford - Wellcome Trust Centre for Human Genetics

Old Road Campus

Roosevelt Drive

Oxford, OX3 7FZ

United Kingdom

SCHOLARLY PAPERS

2

DOWNLOADS

197

SSRN CITATIONS

6

CROSSREF CITATIONS

0

Scholarly Papers (2)

1.

Sustained T Cell Immunity, Protection and Boosting Using Extended Dosing Intervals of BNT162b2 mRNA Vaccine

Number of pages: 93 Posted: 21 Jul 2021
Newcastle University - Translational and Clinical Research Institute Immunity and Inflammation Theme, University of Oxford - Wellcome Trust Centre for Human Genetics, University of Liverpool - NIHR Health Protection Research Unit in Emerging and Zoonotic Infections, Oxford University Hospitals NHS Foundation TrustUniversity of Oxford - Nuffield Department of Clinical Neurosciences, University of Oxford - Wellcome Centre for Human Genetics, University of Oxford - Peter Medawar Building for Pathogen Research, Sheffield Teaching Hospitals NHS Foundation Trust, University of Birmingham - Institute of Cancer and Genomic Sciences, University of Birmingham - Institute of Cancer and Genomic Science, University of Liverpool - NIHR Health Protection Research Unit in Emerging and Zoonotic Infections, University of Oxford - Wellcome Trust Centre for Human Genetics, University of Liverpool - NIHR Health Protection Research Unit in Emerging and Zoonotic Infections, University of Sheffield - Department of Infection, Immunity & Cardiovascular Disease, University of Sheffield - Department of Infection, Immunity and Cardiovascular Disease, Public Health England Colindale, University of Liverpool - NIHR Health Protection Research Unit in Emerging and Zoonotic Infections, Oxford University Hospitals NHS Foundation Trust, University of Oxford - Wellcome Centre for Human Genetics, Newcastle University - Translational and Clinical Research Institute Immunity and Inflammation Theme, University of Sheffield - Department of Infection, Immunity & Cardiovascular Disease, University of Sheffield - Department of Infection, Immunity & Cardiovascular Disease, Newcastle University - Translational and Clinical Research Institute Immunity and Inflammation Theme, Newcastle University - Translational and Clinical Research Institute Immunity and Inflammation Theme, Newcastle University - Translational and Clinical Research Institute Immunity and Inflammation Theme, University of Sheffield - Department of Infection, Immunity & Cardiovascular Disease, Sheffield Teaching Hospitals NHS Foundation Trust, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford, University Hospitals Birmingham NHS Foundation Trust, Public Health England Colindale, Public Health England Colindale, Oxford University Hospitals NHS Foundation Trust, University of Oxford - Peter Medawar Building for Pathogen Research, University of Liverpool - Institute of Infection, Veterinary and Ecological Sciences, Oxford University Hospitals NHS Foundation Trust, Oxford University Hospitals NHS Foundation Trust, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford - Oxford Vaccine Group, University of Oxford - Centre for Vaccinology and Tropical Medicine, University of Oxford - Peter Medawar Building for Pathogen Research, Sheffield Teaching Hospitals NHS Foundation Trust, University of Oxford - Wellcome Trust Centre for Human Genetics, Oxford University Hospitals NHS Foundation Trust, University of Oxford - NIHR Health Protection Research Unit in Healthcare Associated Infection and Antimicrobial Resistance, Public Health England Colindale, Newcastle upon Tyne Hospitals NHS Foundation Trust - Department of Infection and Tropical Medicine, University of Birmingham - Institute of Cancer and Genomic Sciences, University of Oxford - Wellcome Centre for Human Genetics, University of Oxford - Wellcome Centre for Human Genetics, University of Sheffield - Department of Infection, Immunity & Cardiovascular Disease, University of Liverpool - NIHR Health Protection Research Unit in Emerging and Zoonotic Infections, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford - Peter Medawar Building for Pathogen Research and Independent
Downloads 155 (260,456)
Citation 6

Abstract:

Loading...

Neutralization of SARS-CoV-2 by Destruction of the Prefusion Spike

Number of pages: 58 Posted: 01 Jun 2020
University of Oxford - Division of Structural Biology, University of Oxford - Division of Structural Biology, University of Oxford - Division of Structural Biology, University of Oxford - Division of Structural Biology, University of Oxford - Division of Structural Biology, Public Health England - National Infection Service, University of Oxford - Division of Structural Biology, University of Oxford - Division of Structural Biology, University of Oxford - Division of Structural Biology, University of Oxford - Division of Structural Biology, University of Oxford - MRC Human Immunology Unit, University of Oxford - MRC Human Immunology Unit, Public Health England - National Infection Service, Public Health England - National Infection Service, Public Health England - National Infection Service, Diamond Light Source, Harwell Science and Innovation Campus, Diamond Light Source - Harwell Science and Innovation Campus, University of Oxford - Wellcome Trust Centre for Human Genetics, University of Oxford - Wellcome Trust Centre for Human Genetics, University of Oxford - Wellcome Trust Centre for Human Genetics, Public Health England - National Infection Service, University of Oxford - MRC Human Immunology Unit, University of Oxford - Division of Structural Biology, University of Oxford - Division of Structural Biology and Weizmann Institute of Science - Department of Biomolecular Sciences
Downloads 24 (684,037)
Citation 3

Abstract:

Loading...

SARS-CoV-2, Spike, X-ray crystallography, Cryo-EM, Neutralisation, Monoclonal antibody, neutralising monoclonal antibody, COVID-19

Neutralization of SARS-CoV-2 by Destruction of the Prefusion Spike

Number of pages: 53 Posted: 12 May 2020
University of Oxford - Division of Structural Biology, University of Oxford - Division of Structural Biology, University of Oxford - Division of Structural Biology, University of Oxford - Division of Structural Biology, University of Oxford - Division of Structural Biology, Public Health England - National Infection Service, University of Oxford - Division of Structural Biology, University of Oxford - Division of Structural Biology, University of Oxford - Division of Structural Biology, University of Oxford - Division of Structural Biology, University of Oxford - MRC Human Immunology Unit, University of Oxford - MRC Human Immunology Unit, Public Health England - National Infection Service, Public Health England - National Infection Service, Diamond Light Source, Harwell Science and Innovation Campus, Diamond Light Source - Harwell Science and Innovation Campus, University of Oxford - Wellcome Trust Centre for Human Genetics, University of Oxford - Wellcome Trust Centre for Human Genetics, University of Oxford - Wellcome Trust Centre for Human Genetics, Public Health England - National Infection Service, University of Oxford - MRC Human Immunology Unit, University of Oxford - Division of Structural Biology, University of Oxford - Division of Structural Biology and Weizmann Institute of Science - Department of Biomolecular Sciences
Downloads 18 (733,733)
Citation 1

Abstract:

Loading...

Covid-19, SARS-CoV-2, Antibody Structure, Spike, Receptor Binding Domain, Neutralisation, Therapeutic Antibody, Crystallography, Cryo-EM, virus structure